Publications
Publications
Show Results For
- All HBS Web
(631)
- Faculty Publications (132)
- November 2002 (Revised June 2003)
- Case
Corning, Inc.: Technology Strategy in 2003
Corning, Inc. has a 150-year history of building a strategy around innovation. Founded as a glass manufacturer in 1851, the company quickly established itself as a maker of specialty glass products and over the next 100 years diversified into light bulbs, television,... View Details
- August 2002 (Revised December 2003)
- Case
Italy: A New Commitment to Growth
By: Richard H.K. Vietor and Rebecca Evans
Examines Italy's efforts to comply with the Maastricht Treaty and become integrated with Europe in the European Union. By 2002, Italy has achieved macroeconomic stability, but slow growth threatens the country's future competitiveness. Prime Minister Silvio Berlusconi... View Details
- March 2002 (Revised March 2008)
- Case
Saudi Arabia: Getting the House in Order
By: Richard H.K. Vietor and Rebecca Evans
Provides a vehicle to explore Islamic development and political issues within BGIE (business, government, and international economy). Set in early 2002, the case focuses on Crown Prince Abdullah's efforts to liberalize a failing rentier state, that had been dependent... View Details
- January 2002
- Article
Putting Patents in Context: Exploring Knowledge Transfer from MIT
By: Ajay Agrawal and Rebecca M. Henderson
- July 2001 (Revised June 2005)
- Case
Japan: Beyond the Bubble
By: Richard H.K. Vietor and Rebecca Evans
By the summer of 2001, Japan's economy had been generally stagnant for nearly 10 years--since the collapse of the bubble economy in 1990-91. The development strategy that drove the nation during earlier decades was fulfilled, and by 1989 Japan's GDP per capita exceeded... View Details
- 2001
- Chapter
Publicly Funded Science and the Productivity of the Pharmaceutical Industry
By: Rebecca Henderson and Ian Cockburn
U.S. taxpayers funded $14.8 billion of health related research last year, four times the amount that was spent in 1970 in real terms. In this paper we evaluate the impact of these huge expenditures on the technological performance of the pharmaceutical industry. While... View Details
- Article
Scale and Scope in Drug Development: Unpacking the Advantages of Size in Pharmaceutical Research
By: Rebecca Henderson and Iain Cockburn
- 2000
- Chapter
'Luck', 'Leadership' and 'Strategy'
- 2000
- Chapter
Measuring Competence? Exploring Firm Effects in Drug Discovery
By: Rebecca M. Henderson and Iain Cockburn
- fall 2000
- Article
Putting Patents in Context: Exploring Knowledge Transfer from MIT
By: Rebecca M. Henderson and Ajay Agrawal
- July – August 2000
- Article
Drug Industry Mergers Won't Necessarily Benefit R&D
- Article
Absorptive Capacity, Coauthoring Behavior, and the Organization of Research in Drug Discovery
By: Rebecca M. Henderson and Iain Cockburn
- Article
The Interactions of Organizational and Competitive Influences on Strategy and Performance
By: Rebecca M. Henderson and Will Mitchell
- 1996
- Chapter
The Determinants of Research Productivity in Ethical Drug Discovery
By: Rebecca M. Henderson and Ian Cockburn
- Article
Scale and Scope in Drug Development: Unpacking the Advantages of Size in Pharmaceutical Research
By: Rebecca M. Henderson and Iain Cockburn
- spring 1996
- Article
Scale, Scope and Spillovers: The Determinants of Research Productifity in Drug Discovery
By: Rebecca M. Henderson and Ian Cockburn
- July 1995
- Article
Of Life Cycles Real and Imaginary: The Unexpectedly Long Old Age of Optical Lithography
Keywords: Health